FLAM
First Light Asset Management Portfolio holdings
AUM
$771M
1-Year Return
33.17%
This Quarter Return
-12.58%
1 Year Return
+33.17%
3 Year Return
+208.13%
5 Year Return
+426.73%
10 Year Return
+3,318.8%
AUM
$202M
AUM Growth
-$10.1M
(-4.7%)
Cap. Flow
+$23.3M
Cap. Flow
% of AUM
11.5%
Top 10 Holdings %
Top 10 Hldgs %
49.35%
Holding
66
New
5
Increased
31
Reduced
3
Closed
4
Top Buys
| 1 |
DOC
PHYSICIANS REALTY TRUST
DOC
|
$4.86M |
| 2 |
ENTL
Entellus Medical, Inc. Common Stock
ENTL
|
$4.37M |
| 3 |
MDCO
Medicines Co
MDCO
|
$3.19M |
| 4 |
AtriCure
ATRC
|
$2.77M |
| 5 |
Arrowhead Research
ARWR
|
$2.68M |
Top Sells
| 1 |
AMAG
AMAG Pharmaceuticals, Inc.
AMAG
|
$7.83M |
| 2 |
NXTM
NxStage Medical Inc.
NXTM
|
$3.32M |
| 3 |
Standard BioTools
LAB
|
$2.38M |
| 4 |
Verastem
VSTM
|
$1.72M |
| 5 |
ELGX
Endologix Inc
ELGX
|
$1.52M |
Sector Composition
| 1 | Healthcare | 83.82% |
| 2 | Energy | 3.37% |
| 3 | Real Estate | 2.4% |
| 4 | Financials | 0.28% |
| 5 | Consumer Staples | 0.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CPHD
26
DELISTED
Cepheid Inc
CPHD
| $2.91M | 1.44% |
64,271
+9,580
| +18% | +$433K |
|
|
STRM
27
DELISTED
Streamline Health Solutions
STRM
| $2.87M | 1.42% |
83,677
+11,182
| +15% | +$384K |
|
|
28
Arrowhead Research
ARWR
$3.87B
| $2.68M | 1.32% |
+465,503
| New | +$2.68M |
|
29
Veracyte
VCYT
$2.48B
| $2.65M | 1.31% |
564,932
+82,669
| +17% | +$388K |
|
30
HealthStream
HSTM
$836M
| $2.58M | 1.28% |
118,352
+17,598
| +17% | +$384K |
|
31
Vertex Pharmaceuticals
VRTX
$102B
| $2.57M | 1.27% |
24,643
+3,545
| +17% | +$369K |
|
32
Celldex Therapeutics
CLDX
$1.51B
| $2.27M | 1.12% |
14,342
+1,986
| +16% | +$314K |
|
|
ELGX
33
DELISTED
Endologix Inc
ELGX
| $2.22M | 1.1% |
18,096
-12,364
| -41% | -$1.52M |
|
34
BioMarin Pharmaceuticals
BMRN
$10.9B
| $2.02M | 1% |
19,153
+2,788
| +17% | +$294K |
|
35
Karyopharm Therapeutics
KPTI
$58.4M
| $1.63M | 0.8% |
+10,314
| New | +$1.63M |
|
|
BLUE
36
DELISTED
bluebird bio
BLUE
| $1.17M | 0.58% |
1,052
+156
| +17% | +$173K |
|
37
Esperion Therapeutics
ESPR
$510M
| $1.13M | 0.56% |
47,965
+28,035
| +141% | +$661K |
|
|
PETX
38
DELISTED
Aratana Therapeutics, Inc.
PETX
| $701K | 0.35% |
82,911
+12,291
| +17% | +$104K |
|
39
Humana
HUM
$37.5B
| $634K | 0.31% |
3,540
| – | – |
|
40
Elevance Health
ELV
$69.4B
| $573K | 0.28% |
4,095
| – | – |
|
|
AET
41
DELISTED
Aetna Inc
AET
| $571K | 0.28% |
5,215
| – | – |
|
|
ENDP
42
DELISTED
Endo International plc
ENDP
| $565K | 0.28% |
8,161
| – | – |
|
43
Novartis
NVS
$249B
| $558K | 0.28% |
6,774
| – | – |
|
|
AGN
44
DELISTED
Allergan plc
AGN
| $553K | 0.27% |
2,035
| – | – |
|
45
United Therapeutics
UTHR
$17.2B
| $501K | 0.25% |
3,820
| – | – |
|
46
Bristol-Myers Squibb
BMY
$95B
| $491K | 0.24% |
8,290
| – | – |
|
|
CELG
47
DELISTED
Celgene Corp
CELG
| $463K | 0.23% |
4,280
| – | – |
|
48
Eli Lilly
LLY
$666B
| $460K | 0.23% |
5,495
| – | – |
|
49
Becton Dickinson
BDX
$54.8B
| $450K | 0.22% |
3,480
| – | – |
|
50
Steris
STE
$24B
| $411K | 0.2% |
6,330
| – | – |
|